InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Aliski William, Director. Director active across 1 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was disclosed on 24 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
02,145 shares0
Common Stock
SEC:0001209191-21-043547·
02,145 shares0
Common Stock
SEC:0001209191-21-043547:0·
2 of 2 declarations
About Aliski William
William Aliski is a Board Member at Ultragenyx Pharmaceutical Inc. He brings his expertise in corporate governance and strategy to the leadership team. Ultragenyx is dedicated to discovering and developing treatments for rare diseases. As a Board Member, William Aliski plays a key role in the strategic direction of the company, ensuring it remains aligned with its research and development goals.
